Completed PHASE4 INTERVENTIONAL 1-arm NCT00911976

Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions (SOS-Xience V)

Prospective Evaluation of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: The Stenting Of Saphenous Vein Grafts Xience V Angiographic Study (SOS-Xience V)

Sponsor: North Texas Veterans Healthcare System

Conditions Atherosclerosis Coronary Artery Bypass

Interventions Xience V coronary stent

Updated 5 times since 2017 Last updated: Oct 25, 2012 Started: May 31, 2009 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Atherosclerosis and Coronary Artery Bypass and is currently completed. North Texas Veterans Healthcare System leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

North Texas Veterans Healthcare System

Data source: North Texas Veterans Healthcare System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States